ASX - By Stock
|
CHM |
Re:
Ann: AGM Presentation
|
|
tealblue
|
19 |
6.5K |
1 |
17/11/22 |
17/11/22 |
ASX - By Stock
|
19
|
6.5K
|
1
|
|
ASX - By Stock
|
CHM |
Re:
Ann: AGM Presentation
|
|
tealblue
|
19 |
6.5K |
0 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
19
|
6.5K
|
0
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Appendix 4C - 30 September 2022
|
|
tealblue
|
23 |
6.9K |
1 |
28/10/22 |
28/10/22 |
ASX - By Stock
|
23
|
6.9K
|
1
|
|
ASX - By Stock
|
NGS |
Re:
Ann: Nutritional Growth Solutions positive clinical trial results
|
|
tealblue
|
4 |
2.3K |
1 |
18/10/22 |
18/10/22 |
ASX - By Stock
|
4
|
2.3K
|
1
|
|
ASX - By Stock
|
NGS |
Re:
Ann: Quarterly Activities and Cash Flow Report - June 2022
|
|
tealblue
|
5 |
2.5K |
0 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
5
|
2.5K
|
0
|
|
ASX - By Stock
|
CIM |
Re:
Ann: Supplementary Target's Statement
|
|
tealblue
|
21 |
13K |
0 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
21
|
13K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Appendix 4C and Activities Report for June 2022 Quarter
|
|
tealblue
|
119 |
32K |
3 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
119
|
32K
|
3
|
|
ASX - By Stock
|
NGS |
Re:
Ann: NGS accelerates rollout in US with UNFI distribution deal
|
|
tealblue
|
1 |
757 |
2 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
1
|
757
|
2
|
|
ASX - By Stock
|
CIM |
Re:
Ann: Supplementary Target's Statement
|
|
tealblue
|
21 |
13K |
0 |
06/07/22 |
06/07/22 |
ASX - By Stock
|
21
|
13K
|
0
|
|
ASX - By Stock
|
CIM |
Re:
Ann: Supplementary Target's Statement
|
|
tealblue
|
21 |
13K |
0 |
27/06/22 |
27/06/22 |
ASX - By Stock
|
21
|
13K
|
0
|
|
ASX - By Stock
|
CHM |
Re:
Ann: A$30 million Equity Placement Agreement with L1 Capital
|
|
tealblue
|
43 |
17K |
12 |
09/06/22 |
09/06/22 |
ASX - By Stock
|
43
|
17K
|
12
|
|
ASX - By Stock
|
NGS |
Re:
Ann: Quarterly Activities and Cash Flow Report - March 2022
|
|
tealblue
|
1 |
1.1K |
0 |
29/04/22 |
29/04/22 |
ASX - By Stock
|
1
|
1.1K
|
0
|
|
ASX - By Stock
|
CIM |
Re:
Ann: Variation of Takeover Bid
|
|
tealblue
|
9 |
4.0K |
0 |
11/04/22 |
11/04/22 |
ASX - By Stock
|
9
|
4.0K
|
0
|
|
ASX - By Stock
|
CIM |
Re:
Ann: Variation of Takeover Bid
|
|
tealblue
|
9 |
4.0K |
3 |
11/04/22 |
11/04/22 |
ASX - By Stock
|
9
|
4.0K
|
3
|
|
ASX - By Stock
|
CIM |
Re:
Ann: Change in substantial holding
|
|
tealblue
|
2 |
1.0K |
0 |
07/04/22 |
07/04/22 |
ASX - By Stock
|
2
|
1.0K
|
0
|
|
ASX - By Stock
|
NGS |
Re:
Ann: NGS launches a new product line in North America
|
|
tealblue
|
4 |
2.4K |
3 |
06/04/22 |
06/04/22 |
ASX - By Stock
|
4
|
2.4K
|
3
|
|
ASX - By Stock
|
CIM |
Re:
Cimic Group Takeover @ $22.
|
|
tealblue
|
2 |
1.2K |
2 |
29/03/22 |
29/03/22 |
ASX - By Stock
|
2
|
1.2K
|
2
|
|
ASX - By Stock
|
CHM |
Re:
My analysis and intrinsic value of CHM March 2022
|
|
tealblue
|
13 |
5.4K |
5 |
29/03/22 |
29/03/22 |
ASX - By Stock
|
13
|
5.4K
|
5
|
|
ASX - By Stock
|
TLX |
Re:
My analysis and intrinsic value of TLX March 2022
|
|
tealblue
|
82 |
43K |
3 |
28/03/22 |
28/03/22 |
ASX - By Stock
|
82
|
43K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Pause in Trading
|
|
tealblue
|
1 |
656 |
2 |
23/03/22 |
23/03/22 |
ASX - By Stock
|
1
|
656
|
2
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Extension of Closing Date for Retail Entitlement Offer
|
|
tealblue
|
36 |
14K |
8 |
20/03/22 |
20/03/22 |
ASX - By Stock
|
36
|
14K
|
8
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Extension of Closing Date for Retail Entitlement Offer
|
|
tealblue
|
36 |
14K |
9 |
11/03/22 |
11/03/22 |
ASX - By Stock
|
36
|
14K
|
9
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Next Science SPP Offer Opens
|
|
tealblue
|
6 |
4.0K |
3 |
09/03/22 |
09/03/22 |
ASX - By Stock
|
6
|
4.0K
|
3
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Next Science SPP Offer Opens
|
|
tealblue
|
6 |
4.0K |
1 |
09/03/22 |
09/03/22 |
ASX - By Stock
|
6
|
4.0K
|
1
|
|
ASX - By Stock
|
NGS |
Re:
Ann: NGS Commences Production in New Zealand
|
|
tealblue
|
5 |
2.0K |
2 |
08/03/22 |
08/03/22 |
ASX - By Stock
|
5
|
2.0K
|
2
|
|
ASX - By Stock
|
NGS |
Re:
Ann: NGS Commences Production in New Zealand
|
|
tealblue
|
5 |
2.0K |
2 |
08/03/22 |
08/03/22 |
ASX - By Stock
|
5
|
2.0K
|
2
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Next Science SPP Offer Opens
|
|
tealblue
|
6 |
4.0K |
1 |
04/03/22 |
04/03/22 |
ASX - By Stock
|
6
|
4.0K
|
1
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Entitlement Offer to raise approximately $18.1 million
|
|
tealblue
|
78 |
26K |
3 |
04/03/22 |
04/03/22 |
ASX - By Stock
|
78
|
26K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Entitlement Offer to raise approximately $18.1 million
|
|
tealblue
|
78 |
26K |
4 |
04/03/22 |
04/03/22 |
ASX - By Stock
|
78
|
26K
|
4
|
|
ASX - By Stock
|
NGS |
Re:
Ann: US retail expansion accelerates with Walmart.com approval
|
|
tealblue
|
1 |
707 |
4 |
24/01/22 |
24/01/22 |
ASX - By Stock
|
1
|
707
|
4
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Zimmer complaint
|
|
tealblue
|
67 |
24K |
1 |
24/06/21 |
24/06/21 |
ASX - By Stock
|
67
|
24K
|
1
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Zimmer complaint
|
|
tealblue
|
67 |
24K |
1 |
24/06/21 |
24/06/21 |
ASX - By Stock
|
67
|
24K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Integrity.....
|
|
tealblue
|
190 |
42K |
3 |
17/06/21 |
17/06/21 |
ASX - By Stock
|
190
|
42K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Integrity.....
|
|
tealblue
|
190 |
42K |
3 |
17/06/21 |
17/06/21 |
ASX - By Stock
|
190
|
42K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Myocarditis and COVID vaccines
|
|
tealblue
|
54 |
19K |
6 |
13/06/21 |
13/06/21 |
ASX - By Stock
|
54
|
19K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Myocarditis and COVID vaccines
|
|
tealblue
|
54 |
19K |
3 |
13/06/21 |
13/06/21 |
ASX - By Stock
|
54
|
19K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast in Freefall
|
|
tealblue
|
982 |
287K |
0 |
11/06/21 |
11/06/21 |
ASX - By Stock
|
982
|
287K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast in Freefall
|
|
tealblue
|
982 |
287K |
1 |
11/06/21 |
11/06/21 |
ASX - By Stock
|
982
|
287K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast in Freefall
|
|
tealblue
|
982 |
287K |
1 |
11/06/21 |
11/06/21 |
ASX - By Stock
|
982
|
287K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Where is Novartis?
|
|
tealblue
|
1.5K |
419K |
0 |
08/06/21 |
08/06/21 |
ASX - By Stock
|
1.5K
|
419K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Third Quarter Results Presentation
|
|
tealblue
|
131 |
38K |
2 |
04/06/21 |
04/06/21 |
ASX - By Stock
|
131
|
38K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Third Quarter Results Presentation
|
|
tealblue
|
131 |
38K |
1 |
04/06/21 |
04/06/21 |
ASX - By Stock
|
131
|
38K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Third Quarter Results Presentation
|
|
tealblue
|
131 |
38K |
5 |
04/06/21 |
04/06/21 |
ASX - By Stock
|
131
|
38K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Topline 60-Day Results
|
|
tealblue
|
1.6K |
468K |
2 |
04/06/21 |
04/06/21 |
ASX - By Stock
|
1.6K
|
468K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Q3 Financial Results Webcast
|
|
tealblue
|
300 |
86K |
5 |
03/06/21 |
03/06/21 |
ASX - By Stock
|
300
|
86K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast in Freefall
|
|
tealblue
|
982 |
287K |
6 |
12/05/21 |
12/05/21 |
ASX - By Stock
|
982
|
287K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast in Freefall
|
|
tealblue
|
982 |
287K |
1 |
12/05/21 |
12/05/21 |
ASX - By Stock
|
982
|
287K
|
1
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Notification of forthcoming release of escrowed securities
|
|
tealblue
|
11 |
3.4K |
0 |
12/04/21 |
12/04/21 |
ASX - By Stock
|
11
|
3.4K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Raises US$110M Led By US Strategic Investor Group
|
|
tealblue
|
508 |
173K |
2 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
508
|
173K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Raises US$110M Led By US Strategic Investor Group
|
|
tealblue
|
508 |
173K |
1 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
508
|
173K
|
1
|
|